By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Small-cap stock under ₹50 hits upper circuit, rises over 470% in one year | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Small-cap stock under ₹50 hits upper circuit, rises over 470% in one year | Stock Market News
Business

Small-cap stock under ₹50 hits upper circuit, rises over 470% in one year | Stock Market News

Last updated: April 17, 2026 1:52 pm
3 days ago
Share
SHARE


Shares of Take Solutions were locked in the 2% upper circuit on Friday, April 17, after the company announced its entry into India’s longevity and anti-aging segment.

According to the company’s exchange filing, the initiative aims to leverage its established capabilities in clinical research, life sciences, and regulatory processes to build a scalable platform spanning consumer health products and digital wellness solutions.

The company pointed out that the global longevity market, which was valued at $27.61 billion in 2025, is expected to reach $67.03 billion by 2035, reflecting a CAGR of 9.41%. In India, the potential is growing in sectors such as anti-aging supplements, services, and preventive healthcare, fueled by increased health awareness and a rise in lifestyle-related health issues.

Also Read | Multibagger stock hits upper circuit after launch of AI-driven health platform

Take Solutions intends to implement a dual approach that merges product innovation with technology-driven solutions, featuring science-based nutraceuticals, biohacking products, and predictive digital tools aimed at metabolic health, sleep, cognition, and biological aging, thereby situating itself in a rapidly growing and underpenetrated market.

Parmeshvar Dhangare, Director of Take Solutions Ltd, said – “Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible.”

Also Read | Small-cap index jumps 13%: Should you chase the momentum amid macro woes?

Take Solutions share price today

Take Solutions share price today opened at an intraday high of ₹48.91 apiece and an intraday low of ₹48.85 per share on the BSE.

Take Solutions shares have delivered a strong rally across multiple timeframes, reflecting sustained investor interest. The stock has gained 7.54% over the past week and surged 18.66% in two weeks, indicating sharp near-term momentum. Over a one-month period, it is up 23.23%, while in the last three months it has advanced 17.43%.

On a broader horizon, the performance remains robust, with the stock rising 21.33% on a year-to-date basis and an impressive 138.35% over the past six months. Most notably, it has delivered a remarkable 468.72% return over the last one year, highlighting a strong uptrend and significant wealth creation for investors.

Osho Krishan, Sr. Analyst, Technical & Derivatives, Angel One, said that given that Take Solutions has recently exhibited circuit-level movements, relying solely on technical indicators may not provide a comprehensive view. However, based on historical price trends, the stock appears to face a resistance zone around the 50 level.

“A decisive breakout above this range could potentially drive the price towards the 65–68 zone. On the downside, the 44–40 range is expected to serve as a key support zone,” said Krishan.

Also Read | Small-cap stock under ₹50 extends rally for second straight session

Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.



Source link

You Might Also Like

Access Denied

Access Denied

Access Denied

Access Denied

Access Denied

TAGGED:anti-aging segmentclinical researchdigital wellness solutionshealthcare and regulatory executionlongevity marketsmall cap stockTake Solutions
Share This Article
Facebook Twitter Email Print
Previous Article Access Denied
Next Article Multibagger defence stock Apollo Micro Systems zooms 16% after this nod from the Government of India | Stock Market News
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS